Stephen E. Langabeer

4.3k citations
104 papers · 2.7k · 1 hit paper · h-index 20

Impact in

  • Hematology top 0.2%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 1%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Myeloproliferative Neoplasms: Diagnosis and Treatment 47
    • Chronic Lymphocytic Leukemia Research 22
    • Acute Myeloid Leukemia Research 39
    • Chronic Myeloid Leukemia Treatments 37

Stephen E. Langabeer

96 papers receiving 2.7k citations

Stephen E. Langabeer's Hit Papers

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials 2001 · 1.2k citations
1.2k0+8+16Years since publication2505007501000

Peers

Stephen E. Langabeer
Comparison fields: 5 of 60
  • Hematology 2.1k
  • Genetics 863
  • Public Health, Environmental and Occupational Health 505
  • Molecular Biology 1.2k
  • Rheumatology 185
Replace Giovanna Rege‐Cambrin with:
Giovanna Rege‐Cambrin Italy
Brenton G. Mar United States
Toshiko Motoji Japan
S Yokota Japan
Jalaja Potluri United States
Christine Arnoulet France
Itsuro Jinnai Japan
Mario Sessarego Italy
Laurence Legros France
Lydia Roy France
Stephen E. Langabeer relative to Giovanna Rege‐Cambrin Italy Giovanna Rege‐Cambrin's profile →
Citations per field
00.5×1.5×2.1×
Giovanna Rege‐Cambrin · 1×
Citations per year

Countries citing papers authored by Stephen E. Langabeer

Since Specialization
Citations

This map shows the geographic impact of Stephen E. Langabeer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen E. Langabeer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen E. Langabeer more than expected).

Fields of papers citing papers by Stephen E. Langabeer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen E. Langabeer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen E. Langabeer. The network helps show where Stephen E. Langabeer may publish in the future.

Co-authors

The 25 scholars most cited alongside Stephen E. Langabeer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen E. Langabeer Line = papers co-authored together Stephen E. Langabeer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 104 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
Hit paper breakdown →
20011183
2 2002239
3 1999210
4
Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia.
1997101
5 199778
6 199774
7 201261
8 200461
9
Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse.
199659
10 200247
11 201545
12 200142
13 200331
14 199931
15 199530
16 199926
17 201223
18 199922
19 201221
20 199720

About Stephen E. Langabeer

Stephen E. Langabeer is a scholar working on Genetics, Hematology, Molecular Biology, Rheumatology and Public Health, Environmental and Occupational Health, having authored 104 papers that have together received 2.7k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (47 papers), Acute Myeloid Leukemia Research (39 papers), Chronic Myeloid Leukemia Treatments (37 papers), Eosinophilic Disorders and Syndromes (32 papers), Chronic Lymphocytic Leukemia Research (22 papers), Kruppel-like factors research (17 papers), Acute Lymphoblastic Leukemia research (11 papers) and Retinoids in leukemia and cellular processes (10 papers). The work is most often cited by research in Hematology (2.1k citations), Genetics (863 citations), Public Health, Environmental and Occupational Health (505 citations), Molecular Biology (1.2k citations) and Rheumatology (185 citations). Stephen E. Langabeer has collaborated with scholars based in Ireland, United Kingdom and United States. Frequent co-authors include David C. Linch, Alan K. Burnett, Rosemary E. Gale, David Bowen, Marion E. Frew, Panagiotis Kottaridis, Keith Wheatley, Anthony H. Goldstone, Helen M. Walker and G Harrison. Their work appears in journals such as British Journal of Haematology, Blood, Molecular Diagnosis & Therapy, Leukemia Research and Pediatric Blood & Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact